Lecture 45 Flashcards
HMP Shunt and RBC Metabolism
1
Q
RBC function
A
transport of oxygen from lungs to tissues
pg 1176
2
Q
RBC structure
A
- lack nucleus and membrane-bound cellular organelles
- shaped as a biconcave disc to maximize the cell surface for gas exchange
- extremely flexible to pass through narrow capillaries
pg 1176
3
Q
RBC life
A
- short life span -> average of 120 days
- fast turnover -> 1012 RBC produced daily
pg 1176
4
Q
RBC metabolism overview
A
- no mitochdondria, no ER, etc -> no fatty acids used for energy
- glycolysis: synthesis of ATP (2 per 1 glucose), production of 2,3 BPG (bisphosphoglycerate), and reduction of Fe3+ to Fe2+ (2+ can reversibly bind to O2
- pentose phosphate pathway (PPP) or hexose monophosphate shunt (HMP shunt): role of NADPH in RBC
pg 1177
5
Q
anaerobic glycolysis
A
- for 1 glucose: 2 ATP net energy yield, 2 NADH, 2 pyruvate
- NAD+ is regenerated through lactate production (to keep glycolysis going by converting pyruvate to lactic acid)
- lactate is sent to the liver (part of Cori cycle) for production of glucose via gluconeogenesis
pg 1179
6
Q
GLUT 1
A
- distribution: human erthyrocyte, blood-brain barrier, blood-retinal barrier, blood-placental barrier, blood-testis barrier
- expressed in cell types with barrier functions
- high-affinity glucose transport system
- RBCs rely exclusively on glucose for energy and require this transporter
pg 1180
7
Q
pyruvate kinase deficiency
A
- RBCs have their own type of pyruvate kinase for use in glycolysis
- results in hemolytic anemia (nonspherocytic)
- symptoms: fatigue, unusually pale skin, SOB, jaundice, increased risk of gallstones
pg 1182
8
Q
pyruvate kinase deficiency vs G6PD deficiency
A
- G6PD deficiency most common cause of hemolytic anemia -> pyruvate kinase deficiency is 2nd most common
- distinguish: pyruvate kinase deficiency has lack of Heinz bodies (precipitated hemoglobin)
pg 1182
9
Q
2,3-bisphosphoglycerate (2,3-BPG)
A
- formed from 1,3-BPG via a mutase
- allosteric regulator of O2 binding to Hb
- most abundant organophosphate in RBC
- rapidly degraded in blood stored for transfusion
- increased in adapting to high altitudes
pg 1183
10
Q
hemoproteins
A
- in hemoglobin (transport) and myoglobin (storage in muscle), iron must be in Fe2+ form to reversibly bind oxygen
- cytochrome can be in either form and has function in ETC
- cytochrome P450 can be in either form and has function in hydroxylation
- catalase can be in either form and functions in degradation of H2O2
pg 1185
11
Q
heme iron oxidation
A
- hemoglobin (Fe2+) oxidized by drugs and endogenous oxidants to methemoglobin (Fe3+)
- metHb unable to bind O2 and leads to methemoglobinemia
- metHb reduced to Hb by NADH-cytochrome b5 reductase
pg 1186
12
Q
methemoglobinemia
A
- “chocolate cyanosis” -> blue coloration of the skin and mucous membranes, brown-colored blood as a result of the dark-colored metHb
- babies have half the capacity to reduce metHb
pg 1186
13
Q
methemoglobinemia symptoms and treatment
A
Symptoms
- related to degree of tissue hypoxia
- anxiety, headache, and dyspnea
- rarely -> coma and death when metHb is more than 70%
Treatments
- methylene blue (a reducing agent) -> reduces metHb back to Hb and shows results within minutes
pg 1186
14
Q
acquired methemoglobinemia
A
- oxidative stress
- certain drugs and/or their metabolites causing inability to maintain iron in its Fe2+ state
pg 1187
15
Q
congenital methemoglobinemia
A
- deficiency of NADH-cytochrome b5 reductase
- mutations in the α- or β- globin chain producing abnormal HbM resistant to the reductase (rare)
pg 1187